These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 440074)

  • 21. [A contribution to the study of blood platelet aggregation].
    Pstruzinová H; Goderová Z; Kristan M
    Cas Lek Cesk; 1982 Nov; 121(47):1462-5. PubMed ID: 7151112
    [No Abstract]   [Full Text] [Related]  

  • 22. The prevention of thrombosis.
    Bove LG
    J Maine Med Assoc; 1974 Oct; 65(10):233-5. PubMed ID: 4610070
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of platelet adhesion to rabbit aorta by sulphinpyrazone and acetylsalicylic acid.
    Essien EM; Mustard JF
    Atherosclerosis; 1977 May; 27(1):89-95. PubMed ID: 856231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of heparin and polymorphonuclear neutrophil leukocytes on platelet aggregate formation on collagen-coated tubes.
    Adams GA; McIntire LV; Martin RR; Olson JD; Sybers H
    Trans Am Soc Artif Intern Organs; 1982; 28():444-50. PubMed ID: 7164278
    [No Abstract]   [Full Text] [Related]  

  • 25. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 26. An in vitro method for platelet morphological studies employing a reconstituted collagen substrate.
    Albert EN; Daniel RE; Whiting JD; Bailey JM
    Scan Electron Microsc; 1979; (3):131-8. PubMed ID: 392702
    [No Abstract]   [Full Text] [Related]  

  • 27. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis.
    Philp RB; Francey I; Warren BA
    Haemostasis; 1978; 7(5):282-93. PubMed ID: 689491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biphasic initial phase of platelet aggregation inhibition after oral aspirin.
    Walter E; Zimmermann R; Siess R; Staiger C; Weber E
    Artery; 1980; 8(5):501-6. PubMed ID: 7213053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inhibition of collagen-induced thrombocyte aggregation in vivo and in vitro with special reference to acetylsalicylic acid].
    Seuter F
    Med Welt; 1976 Jul; 27(28):1356-9. PubMed ID: 957960
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of heparin, acetylsalicylic acid and sulfinpyrazone on thrombocyte morphology].
    Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Mar; 30(10):365-9. PubMed ID: 763120
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfinpyrazone and aspirin increase epicardial coronary collateral flow in dogs.
    Davenport N; Goldstein RE; Capurro N; Lipson LC; Bonow RO; Shulman NR; Epstein SE
    Am J Cardiol; 1981 Apr; 47(4):848-54. PubMed ID: 7211699
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of platelets in glomerulonephritis.
    George CR; Clark WF; Cameron JS
    Adv Nephrol Necker Hosp; 1975; 5():19-65. PubMed ID: 242207
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
    Karmazyn M; Moffat MP; Beamish RE; Dhalla NS
    J Pharmacol Exp Ther; 1981 Sep; 218(3):764-70. PubMed ID: 6894943
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).
    Feuring M; Haseroth K; Janson CP; Falkenstein E; Schmidt BM; Wehling M
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):584-8. PubMed ID: 10599950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1977 Oct; 121(44):1748-54. PubMed ID: 335258
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of death from myocardial infarction by aspirin and other platelet active drugs.
    Elwood PC
    Clin Cardiol; 1979 Aug; 2(4):241-5. PubMed ID: 400517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.